![]() |
市场调查报告书
商品编码
1326476
伤口治疗市场 - 2018-2028F 全球行业规模、份额、趋势、机会和预测,按治疗、按伤口类型、按应用、按最终用户、按地区和竞争细分Wound Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Therapy, By Wound Type, By Application, By End User, By Region and Competition |
由于人们对伤口护理重要性的认识不断增强以及伤口治疗技术的进步,全球伤口治疗市场预计在预测期内将以惊人的速度增长。多年来,由于慢性伤口发病率的增加以及新型创新伤口护理产品的开发,全球伤口治疗市场出现了显着增长。例如,干细胞在伤口癒合中的应用是一个深入研究的领域,许多公司都在开发基于干细胞的伤口护理产品。伤口护理技术的其他进步包括开发 3D 打印伤口敷料、可以监测伤口癒合的智能敷料以及使用生物粘合剂的伤口闭合装置。
慢性伤口是全球伤口治疗市场的主要驱动力,占整个市场的很大一部分。据美国疾病控制与预防中心 (CDC) 统计,美国约有 650 万人患有慢性伤口,每年治疗这些伤口的费用估计在 281 亿美元至 317 亿美元之间。伤口处理的总成本包括用品和敷料、护理时间和住院费用。一次又一次更换伤口敷料增加了伤口护理的总体成本,从而需要开发更先进的伤口治疗方案,从而支持全球伤口治疗市场的增长。
使用传统方法进行伤口治疗的高昂成本导致了新的和创新疗法的开发,例如基于细胞的治疗或皮肤替代品或使用由生物材料製成的伤口敷料等。
细胞是伤口治疗不可或缺的一部分,它们的使用彻底改变了我们伤口癒合的方式。伤口是皮肤或粘膜破裂的开放性损伤,可由多种因素引起,如外伤、手术或慢性疾病。身体癒合伤口的能力取决于多种因素,例如伤口的范围和位置、患者的健康状况以及是否存在任何潜在的医疗状况。细胞通过替换受损组织并促进新组织的生长,在伤口癒合过程中发挥着至关重要的作用。它们可以多种形式使用,包括基于细胞的疗法、干细胞和皮肤替代品,以增强癒合过程。基于细胞的疗法涉及使用活细胞来促进癒合并改善受损组织的功能。这些疗法通常用于慢性伤口,即使经过常规伤口护理也无法癒合。不同类型的细胞,包括成纤维细胞、角质形成细胞和内皮细胞,可用于促进伤口癒合。成纤维细胞是产生胶原蛋白的细胞,胶原蛋白是一种赋予组织强度和结构的蛋白质。角质形成细胞是产生角蛋白的细胞,角蛋白是皮肤的重要组成部分。内皮细胞是排列在血管上的细胞,在伤口床新血管的形成中发挥着至关重要的作用。
细胞在伤口治疗中的使用有可能彻底改变整个全球伤口治疗市场。与传统伤口护理方法相比,这些疗法具有多种优势,并且有可能显着改善患者的治疗效果。随着再生医学领域的不断发展,细胞在伤口治疗中的使用可能会变得越来越普遍,为慢性伤口患者带来新的希望,并为未来几年全球伤口治疗市场的增长创造新的前景。
除了新兴的伤口治疗方法外,还有几种替代的伤口治疗方法正在使用,例如加压疗法、伤口负压疗法和高压氧疗法。反过来,这些疗法预计将为未来几年替代伤口治疗疗法市场的增长开闢新的前景。压迫疗法用于治疗容易流血或有形成血栓风险的伤口。该方法涉及使用压缩绷带或长袜对伤口施加压力。压迫疗法最适合四肢伤口,例如静脉溃疡和深静脉血栓形成。负压伤口治疗是一种更先进的伤口治疗形式,用于大的慢性伤口。这种方法涉及对伤口施加真空,通过去除多余的液体和增加血流量来促进癒合。负压伤口治疗最适合未癒合或有感染风险的伤口。高压氧疗法是一种特殊的伤口治疗方式,用于治疗因血流不畅而无法癒合的伤口。这种方法涉及将伤口暴露在高水平的氧气中,通过增加血流量和促进新组织的生长来促进癒合。高压氧疗法最适合大且慢性的伤口。
根据给定的市场数据,TechSci Research 可根据公司的具体需求提供定制服务。该报告可以使用以下自定义选项:
Global Wound Treatment Market is expected to grow at an impressive rate during the forecast period on account of the increasing awareness of the importance of wound care and advances in wound treatment technologies. Over the years, the global wound treatment market has witnessed significant growth on account of the increasing incidences of chronic wounds and the development of new and innovative wound care products. For example, the use of stem cells in wound healing is an area of intense research, with many companies developing stem cell-based wound care products. Other advances in wound care technology include the development of 3D-printed wound dressings, smart dressings that can monitor wound healing, and wound closure devices that use bioadhesives.
The wound treatment market is also being driven by the increasing use of wound care products in surgical procedures. Advances in wound care technology have made it possible to use wound care products to improve outcomes in surgical procedures, leading to an increase in the use of these products in the operating room.
Chronic wounds are a major driver of the global wound treatment market, accounting for a significant portion of the total market. According to the Centers for Disease Control and Prevention (CDC), approximately 6.5 million people in the United States suffer from chronic wounds, and the annual cost of treating these wounds is estimated to be between USD 28.1 billion and USD 31.7 billion. The overall cost of wound management includes supplies and dressings, nursing time, and hospitalization. Changing the wound dressings again and again adds up to the overall cost of wound care, thereby creating a need for the development of more advanced wound treatment options, hence supporting the growth of global wound treatment market.
The high cost of wound treatment using traditional methods has led to the development of new and innovative therapies, such as cell-based treatments or skin substitutes or using wound dressings made up of biomaterials, among others.
Cells are an integral part of wound treatment, and their use has revolutionized the way we approach wound healing. Wounds are open injury that breaks the skin or mucous membranes and can be caused by various factors such as trauma, surgery, or chronic diseases. The ability of the body to heal wounds is dependent on various factors, such as the extent and location of the wound, the patient's health status, and the presence of any underlying medical conditions. Cells play a crucial role in the wound-healing process by replacing damaged tissue and promoting the growth of new tissue. They can be used in a variety of forms, including cell-based therapies, stem cells, and skin substitutes, to enhance the healing process. Cell-based therapies involve using living cells to promote healing and improve the function of the damaged tissue. These therapies are often used in chronic wounds, which fail to heal even after conventional wound care. Different types of cells, including fibroblasts, keratinocytes, and endothelial cells, can be used to promote wound healing. Fibroblasts are cells that produce collagen, a protein that gives strength and structure to tissues. Keratinocytes are cells that produce keratin, a protein that is an essential component of skin. Endothelial cells are cells that line the blood vessels and play a vital role in the formation of new blood vessels in the wound bed.
The use of cells in wound treatment has the potential to revolutionize the overall global wound treatment market. These therapies offer several advantages over traditional wound care methods and have the potential to significantly improve patient outcomes. As the field of regenerative medicine continues to evolve, the use of cells in wound treatment is likely to become increasingly common, offering new hope for patients suffering from chronic wounds and creating new prospects for the growth of global wound treatment market in the coming years.
Apart from the emerging wound treatments, there are several alternative wound treatment therapies, such as compression therapy, negative wound pressure therapy, and hyperbaric oxygen therapy, which are being used. These therapies are, in turn, expected to open new prospects for the growth of the alternative wound treatment therapies market in the coming years. Compression therapy is used to treat wounds that have a tendency to bleed or are at risk of developing blood clots. This method involves applying pressure to the wound using compression bandages or stockings. Compression therapy is most appropriate for wounds that are on the limbs, such as venous ulcers and deep vein thrombosis. Negative pressure wound therapy is a more advanced form of wound treatment that is used for large, chronic wounds. This method involves applying a vacuum to the wound, which promotes healing by removing excess fluid and increasing blood flow. Negative pressure wound therapy is most appropriate for wounds that are not healing or are at risk of becoming infected. Hyperbaric oxygen therapy is a specialized form of wound treatment that is used for wounds that are not healing due to poor blood flow. This method involves exposing the wound to high levels of oxygen, which promotes healing by increasing blood flow and promoting the growth of new tissue. Hyperbaric oxygen therapy is most appropriate for wounds that are large and chronic.
Global Wound Treatment Market can be segmented by therapy, wound type, application, end-user, and by region. Based on therapy, global wound treatment market can be categorized into instrumental-based therapy, platelet therapy, cell therapy, and wound dressings. By wound type, the global wound treatment market can be segmented into subcutaneous abdominal wounds, traumatic & infected wounds, bilateral reduction mammaplasty, and others. In terms of application, global wound treatment market can be grouped into burns, ulcers, cuts & lacerations, and others. By end user, the global wound treatment market can be grouped into hospitals & clinics, ambulatory surgery centers, homecare, and others. Regionally, global wound treatment market can be categorized into North America, Europe, Asia Pacific, Middle East & Africa, and South America. The United States dominated the North America market in 2022 and the overall global wound treatment market over other countries on account of the rising patient pool in the country coupled with an increasing geriatric population base which is at a higher risk of developing wounds. This, in turn, is expected to increase the demand for different wound care methods and products, thereby driving the growth of global wound treatment market. According to the Administration for Community Living, which includes the Administration on Aging, which is an operating division of the U.S. Department of Health and Human Services, the population aged 65 and above reached 54.1 million in 2019 from 39.6 million in 2009 and is projected to reach 94.7 million in 2060. By 2040, there will be about 80.8 million older persons, more than twice as many as in 2000. The growing geriatric population will support the growth of global wound treatment market in the coming years. However, the Asia Pacific region is expected to register the highest growth during the forecast period on account of the increasing prevalence of various chronic diseases in the region, especially in the highly populous countries of China and India.
3M Company, ConvaTec Group PLC, Molnlycke Health Care AB, Smith & Nephew plc, Organogenesis, Inc, Coloplast A/S, MiMedx Group, Inc., Integra LifeSciences Corporation, Johnson & Johnson, Medtronic Plc., among others are some of the leading players operating in the global wound treatment market.
In this report, Global Wound Treatment Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in Global Wound Treatment Market.
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: